These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23673637)

  • 1. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.
    Volpi C; Fallarino F; Pallotta MT; Bianchi R; Vacca C; Belladonna ML; Orabona C; De Luca A; Boon L; Romani L; Grohmann U; Puccetti P
    Nat Commun; 2013; 4():1852. PubMed ID: 23673637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive oligodeoxynucleotides induced tolerogenic plasmacytoid dendritic cells and ameliorated the experimental autoimmune neuritis.
    Wang YZ; Lv H; Hao YL; Zhang HQ; Li L; Cai GM; Hu M; Jia CX; Feng XG; Kong QX
    Immunol Lett; 2015 Jul; 166(1):13-8. PubMed ID: 25952624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GpC-rich oligonucleotide acts on plasmacytoid dendritic cells to promote immune suppression.
    Volpi C; Fallarino F; Bianchi R; Orabona C; De Luca A; Vacca C; Romani L; Gran B; Grohmann U; Puccetti P; Belladonna ML
    J Immunol; 2012 Sep; 189(5):2283-9. PubMed ID: 22844124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.
    Kim EJ; Lee SM; Suk K; Lee WH
    Immunology; 2012 Mar; 135(3):226-35. PubMed ID: 22043923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO.
    de Luca A; Bozza S; Zelante T; Zagarella S; D'Angelo C; Perruccio K; Vacca C; Carvalho A; Cunha C; Aversa F; Romani L
    Cell Mol Immunol; 2010 Nov; 7(6):459-70. PubMed ID: 20835271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
    Ma C; Spies NP; Gong T; Jones CX; Chu WM
    PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation.
    Cusson-Hermance N; Khurana S; Lee TH; Fitzgerald KA; Kelliher MA
    J Biol Chem; 2005 Nov; 280(44):36560-6. PubMed ID: 16115877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
    Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
    J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.
    Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L
    J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
    Gohda J; Matsumura T; Inoue J
    J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
    Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
    J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells.
    Tsujimura H; Tamura T; Kong HJ; Nishiyama A; Ishii KJ; Klinman DM; Ozato K
    J Immunol; 2004 Jun; 172(11):6820-7. PubMed ID: 15153500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling.
    Naiki Y; Michelsen KS; Zhang W; Chen S; Doherty TM; Arditi M
    J Biol Chem; 2005 Feb; 280(7):5491-5. PubMed ID: 15623538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.
    Planès R; Ben Haij N; Leghmari K; Serrero M; BenMohamed L; Bahraoui E
    J Virol; 2016 Jul; 90(13):5886-5898. PubMed ID: 27053552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.
    Knezević J; Pavlinić D; Rose WA; Leifer CA; Bendelja K; Gabrilovac J; Parcina M; Lauc G; Kubarenko AV; Petricevic B; Vrbanec D; Bulat-Kardum L; Bekeredjian-Ding I; Pavelić J; Dembić Z; Weber AN
    J Biol Chem; 2012 Jul; 287(29):24544-53. PubMed ID: 22613717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
    Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
    Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.